These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35780261)

  • 21. Prolonged adrenal insufficiency following discontinuation of osilodrostat treatment for intense hypercortisolism.
    Ferriere A; Salenave S; Puerto M; Young J; Tabarin A
    Eur J Endocrinol; 2024 Jan; 190(1):L1-L3. PubMed ID: 38123490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osilodrostat oral tablets for adults with Cushing's disease.
    Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):99-109. PubMed ID: 35220871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
    Beauregard C; Dickstein G; Lacroix A
    Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
    Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
    Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
    Fleseriu M; Biller BMK
    Pituitary; 2022 Dec; 25(6):795-809. PubMed ID: 36002784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease.
    Wong A; Eloy JA; Liu JK
    Neurosurg Focus; 2015 Feb; 38(2):E9. PubMed ID: 25639327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach to the Patient Treated with Steroidogenesis Inhibitors.
    Castinetti F; Nieman LK; Reincke M; Newell-Price J
    J Clin Endocrinol Metab; 2021 Jun; 106(7):2114-2123. PubMed ID: 33675650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.
    Thompson SK; Hayman AV; Ludlam WH; Deveney CW; Loriaux DL; Sheppard BC
    Ann Surg; 2007 May; 245(5):790-4. PubMed ID: 17457173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
    van den Bosch OF; Stades AM; Zelissen PM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cushing's syndrome: special issues].
    Goñi Iriarte MJ
    Endocrinol Nutr; 2009 May; 56(5):251-61. PubMed ID: 19627746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
    Greening JE; Brain CE; Perry LA; Mushtaq I; Sales Marques J; Grossman AB; Savage MO
    Horm Res; 2005; 64(3):140-3. PubMed ID: 16192738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osilodrostat - an emerging drug for the medical management of Cushing's disease.
    Witek P; Mehlich A; Stasiewicz A; Jawiarczyk-Przybyłowska A; Bolanowski M
    Endokrynol Pol; 2022; 73(2):371-374. PubMed ID: 35381096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes.
    Chiloiro S; Giampietro A; Raffaelli M; D'Amato G; Bima C; Lauretti L; Anile C; Lombardi CP; Rindi G; Bellantone R; De Marinis L; Pontecorvi A; Bianchi A
    Endocrine; 2019 Dec; 66(3):642-649. PubMed ID: 31583577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation.
    Boronat M; Marrero D; López-Plasencia Y; Barber M; Schamann Y; Nóvoa FJ
    Gynecol Endocrinol; 2011 Sep; 27(9):675-7. PubMed ID: 20923280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates in the outcomes of radiation therapy for Cushing's disease.
    Gheorghiu ML
    Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101514. PubMed ID: 33814300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease.
    Fontaine-Sylvestre C; Létourneau-Guillon L; Moumdjian RA; Berthelet F; Lacroix A
    Pituitary; 2021 Apr; 24(2):207-215. PubMed ID: 33074401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?
    Guerin C; Taieb D; Treglia G; Brue T; Lacroix A; Sebag F; Castinetti F
    Endocr Relat Cancer; 2016 Feb; 23(2):R131-42. PubMed ID: 26739832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.